C12N 9/0051
Acting on a sulfur group of donors
Official title: {acting on a sulfur group of donors (1.8)}
C12N9/0051 (Acting on a sulfur group of donors) appears on 183 US grants and 302 published applications in this corpus.
Search patents in C12N- Granted patents
- 183
- Published applications
- 302
- Assignees
- 184
- Inventors
- 581
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 3 |
| 2003 | 1 | 6 |
| 2004 | 5 | 7 |
| 2005 | 4 | 6 |
| 2006 | 3 | 2 |
| 2007 | 4 | 1 |
| 2008 | 2 | 4 |
| 2009 | 4 | 7 |
| 2010 | 2 | 6 |
| 2011 | 0 | 8 |
| 2012 | 3 | 7 |
| 2013 | 7 | 9 |
| 2014 | 3 | 10 |
| 2015 | 3 | 15 |
| 2016 | 9 | 30 |
| 2017 | 8 | 18 |
| 2018 | 11 | 20 |
| 2019 | 11 | 22 |
| 2020 | 19 | 24 |
| 2021 | 15 | 17 |
| 2022 | 13 | 22 |
| 2023 | 9 | 22 |
| 2024 | 8 | 12 |
| 2025 | 12 | 18 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex E1-α, E1-β, and E2 subunits for the treatment of maple syrup urine disease2 Jun 2026US 12,644,102 B2ModernaTX, Inc.
- Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates12 May 2026US 12,624,375 B2Northwestern University
- Genetically engineered microorganism capable of growing on formate, methanol, methane or CO214 Apr 2026US 12,600,974 B2
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine14 Apr 2026US 12,600,995 B2Wacker Chemie AG
- Optimized SUMF1 genes and expression cassettes and their use6 Jan 2026US 12,516,301 B2The University of North Carolina at Chapel Hill
- Production of a negatively charged oligosaccharide by a cell24 Sep 2026US 2026/0286409 A1Inbiose N.V.
- Isolated mitochondria as delivery vehicles and stimulators of protein synthesis17 Sep 2026US 2026/0272971 A1Minovia Therapeutics Ltd.
- Modified subtilisin proteins & uses thereof6 Aug 2026US 2026/0226447 A1University of Tennessee Research Foundation
- Bioinformatic processes for determination of peptide binding14 May 2026US 2026/0134941 A1Iogenetics, LLC
- E. coli strains having an oxidative cytoplasm19 Mar 2026US 2026/0078337 A1Sutro Biopharma, Inc.
Most cited
By later US patents
- Process for bacterial production of polypeptides265US 5,789,199 AGenentech, Inc. · 1998
- Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells160US 6,083,715 ABoard of Regents, The University of Texas System · 2000
- Process for bacterial production of polypeptides112US 5,639,635 AGenentech, Inc. · 1997
- Targeted therapeutic proteins60US 7,560,424 B2ZyStor Therapeutics, Inc. · 2009
- Methods and systems for chemoautotrophic production of organic compounds46US 8,349,587 B2Ginkgo Bioworks, Inc. · 2013